Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on Jul 25, 2023 8:06pm
157 Views
Post# 35556884

RE:RE:RE:RE:RE:It's time for a takout

RE:RE:RE:RE:RE:It's time for a takoutThat article is only being read by people on this board and there are not many left here after all of THTX's troubles. And the board has degenerated into a lot of complaining{ which drives traffic lower. INstitutions are not going to be buying this stock very often as its market cap is even more tiny than before and the volume in dollar terms is relly low. Even large retail investors might not be interested now. But that can all be taken care of pretty quickly with some good TH-1902 data. Patience is required to get the required data but constant posting of of emotion laden cries of grief over the share price while ignoring the reality of pretty good chance of TH-1902's restarted trial generating good results achieves what exactly???
Trogarzon wrote: It looks good for shure but why does it not trigger buying.   Why can't they get Institutions to pile in the stock at these levels... volume is good now... why the misery of having to go through this because they can't sell their story to others than Dr Hod Dog......


<< Previous
Bullboard Posts
Next >>